PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:08 AM ET

Sponsor Check › Person

DS
No photo found yet (own website and image search run after this page is viewed)

David Schnell

Named as an officer, director or promoter on SEC Form D filings · NJ, MA, CA, NY · Apr 13, 2009 → Oct 13, 2015

9deals (issuers)
$366.2Mreported sold
116investors
34Form D filings
2009–2015years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:18 AM ET · SEC enforcement last checked: Oct 24, 2026, 1:30 AM ET

The short version

David Schnell is listed as a director on 34 SEC Form D filings by 9 issuers between Apr 2009 and Jun 2019. Largest by amount reported sold: NGM BIOPHARMACEUTICALS INC (South San Francisco, CA — biotechnology — 2009–2015; $106M reported sold to 28 investors), Ajax Therapeutics, Inc. (New York, NY — biotechnology — 2019; $95M reported sold to 21 investors), LUX BIOSCIENCES INC (Jersey City, NJ — biotechnology — 2009–2012; $37.9M reported sold to 10 investors), KYTHERA BIOPHARMACEUTICALS INC (Calabasas, CA — pharmaceuticals — 2011; $37.4M reported sold to 20 investors), ALVINE PHARMACEUTICALS INC (San Carlos, CA — other health care — 2013; $26.5M reported sold to 18 investors) and 4 more (all listed below).

What this means A repeat sponsor — 9 separate companies raised money with this person listed as director, over about 10 years. Across those companies the filings report $366.2M sold in total.

Listed alongside Donald J. Hayden (12 shared filings), Martin Vogelbaum (11 shared filings), David Goeddel (10 shared filings), Jin-Long Chen (10 shared filings), Peter Svennilson (10 shared filings) and 67 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 9 bankruptcy cases matching the name listed in Key records below.

What this means 9 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 34 public filings for David Schnell and found 12 differences, 4 worth asking the sponsor about: Amount sold went down between filings; 6 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for David Schnell has not run yet — it is joining a line of 7,521 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (checked Oct 24, 2026) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases + SEC administrative proceedings (sec.gov index, 1995-09-19 → 2026-10-23) — last checked Oct 24, 2026, 1:30 AM ET.

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

9 cases: 9 closed (disposition not in docket feed)

David A. Schnell closed
United States Bankruptcy Court, N.D. Ohio · No. 17-10235 · Filed Jan 17, 2017 · Closed Sep 20, 2017
Role of David A. Schnell: Debtor · Outcome: Case closed 2017-09-20 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 17 federal dockets); court in OH (not a filing state)
David R. Schnell closed
United States Bankruptcy Court, W.D. New York · No. 1-16-11558 · Filed Aug 11, 2016 · Closed Dec 30, 2016
Role of David R. Schnell: Debtor · Outcome: Case closed 2016-12-30 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 17 federal dockets); court in the person's filing state (NY)
David J. Schnell and Rachel C. Schnell closed
United States Bankruptcy Court, N.D. Illinois · No. 15-82383 · Filed Sep 24, 2015 · Closed Jan 4, 2016
Role of David J. Schnell and Rachel C. Schnell: Debtor · Outcome: Case closed 2016-01-04 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 17 federal dockets); court in IL (not a filing state)
David J Schnell and Kathryn A Schnell closed
United States Bankruptcy Court, D. New Jersey · No. 12-18937 · Filed Apr 4, 2012 · Closed Jul 23, 2012
Role of David J Schnell and Kathryn A Schnell: Debtor · Outcome: Case closed 2012-07-23 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 17 federal dockets); court in the person's filing state (NJ)
David S. Schnell closed
United States Bankruptcy Court, C.D. California · No. 6:12-bk-10841 · Filed Jan 11, 2012 · Closed Apr 23, 2012
Role of David S. Schnell: Debtor · Outcome: Case closed 2012-04-23 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 17 federal dockets); court in the person's filing state (CA)
David L. Schnell and Sandra K. Schnell closed
United States Bankruptcy Court, N.D. Mississippi · No. 09-14211 · Filed Aug 18, 2009 · Closed Mar 14, 2011
Role of David L. Schnell and Sandra K. Schnell: Debtor · Outcome: Case closed 2011-03-14 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 17 federal dockets); court in MS (not a filing state)
David M Schnell closed
United States Bankruptcy Court, C.D. California · No. 2:03-bk-32397 · Filed Aug 25, 2003 · Closed Dec 26, 2003
Role of David M Schnell: Debtor · Outcome: Case closed 2003-12-26 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 17 federal dockets); court in the person's filing state (CA)
David T Schnell and April L Schnell closed
United States Bankruptcy Court, N.D. Illinois · No. 03-14176 · Filed Mar 31, 2003 · Closed May 26, 2005
Role of David T Schnell and April L Schnell: Debtor · Outcome: Case closed 2005-05-26 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 17 federal dockets); court in IL (not a filing state)
David L. Schnell and Carlette Schnell closed
United States Bankruptcy Court, C.D. California · No. 9:96-bk-12237 · Filed Jun 6, 1996 · Closed Oct 31, 1996
Role of David L. Schnell and Carlette Schnell: Debtor · Outcome: Case closed 1996-10-31 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 17 federal dockets); court in the person's filing state (CA)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:18 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

12 differences found between the filings for David Schnell — 4 worth asking about (compared 34 filings on Oct 24, 2026)

Worth asking · Dec 22, 2009 – Apr 5, 2010

Amount sold went down between filings — NGM BIOPHARMACEUTICALS INC

The Dec 22, 2009 filing says $26,550,000 sold; the Apr 5, 2010 Form D says $17,029,670 sold — $9,520,330 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D/A (earlier) · Dec 22, 2009 ↗Form D (later) · Apr 5, 2010 ↗NGM BIOPHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Worth asking · Jun 10, 2009 – Jul 17, 2009

Amount sold went down between filings — Gloucester Pharmaceuticals Inc

The Jun 10, 2009 filing says $1,500,000 sold; the Jul 17, 2009 Form D says $500,000 sold — $1,000,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Jun 10, 2009 ↗Form D (later) · Jul 17, 2009 ↗Gloucester Pharmaceuticals Inc — PartnerFacts page ↗
Sources
Worth asking · May 6, 2009 – Jun 10, 2009

Amount sold went down between filings — Gloucester Pharmaceuticals Inc

The May 6, 2009 filing says $1,700,000 sold; the Jun 10, 2009 Form D says $1,500,000 sold — $200,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · May 6, 2009 ↗Form D (later) · Jun 10, 2009 ↗Gloucester Pharmaceuticals Inc — PartnerFacts page ↗
Sources
Worth asking · Mar 10, 2010 – Jun 28, 2019

6 Form Ds were filed more than 15 days after the first sale

Form D filed 138 days after the first sale — NGM BIOPHARMACEUTICALS INC · Form D filed 16 days after the first sale — Ajax Therapeutics, Inc. · Form D filed 24 days after the first sale — NGM BIOPHARMACEUTICALS INC · Form D filed 16 days after the first sale — KYTHERA BIOPHARMACEUTICALS INC · Form D filed 17 days after the first sale — LUX BIOSCIENCES INC · and 1 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Feb 24, 2015 ↗NGM BIOPHARMACEUTICALS INC — PartnerFacts page ↗Form D · Jun 28, 2019 ↗Ajax Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Apr 10, 2009 – Jun 2, 2010

8 offerings changed their target amount between filings

Offering amount changed between filings — Nora Therapeutics, Inc. · Offering amount changed between filings — NGM BIOPHARMACEUTICALS INC · Offering amount changed between filings — NGM BIOPHARMACEUTICALS INC · Offering amount changed between filings — LUX BIOSCIENCES INC · Offering amount changed between filings — Gloucester Pharmaceuticals Inc · and 3 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Apr 13, 2009 ↗Form D/A (later) · Jun 2, 2010 ↗Nora Therapeutics, Inc. — PartnerFacts page ↗Form D (earlier) · Apr 5, 2010 ↗
Sources
Note · Jan 18, 2008 – Oct 13, 2015

14 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Nora Therapeutics, Inc. (latest filing Oct 13, 2015) · No amendment in the last 12 months on an offering that may still be open — NGM BIOPHARMACEUTICALS INC (latest filing Feb 24, 2015) · No amendment in the last 12 months on an offering that may still be open — NGM BIOPHARMACEUTICALS INC (latest filing May 3, 2013) · No amendment in the last 12 months on an offering that may still be open — ALVINE PHARMACEUTICALS INC (latest filing Jan 3, 2013) · No amendment in the last 12 months on an offering that may still be open — LUX BIOSCIENCES INC (latest filing Mar 6, 2012) · and 9 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Oct 13, 2015 ↗Nora Therapeutics, Inc. — PartnerFacts page ↗Form D · Feb 24, 2015 ↗NGM BIOPHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · Jun 2, 2010 – Sep 23, 2010

Address moved from Owing Mills, MD to Palo Alto, CA — Nora Therapeutics, Inc.

The people listed on the Jun 2, 2010 filing give Owing Mills, MD; on the Sep 23, 2010 filing they give Palo Alto, CA. The address now on file (530 Lytton Avenue, 2nd Floor, Palo Alto, CA) is a registered-agent or shared-office address used by 39 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Form D/A · Jun 2, 2010 ↗Form D · Sep 23, 2010 ↗Nora Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Apr 10, 2009 – Jun 28, 2019

David Schnell is listed with 4 different address states: MA, CA, NJ, NY

MA on 7 filings (Apr 10, 2009 to Feb 23, 2012); CA on 19 filings (Apr 13, 2009 to Oct 13, 2015); NJ on 7 filings (Jun 16, 2009 to Mar 6, 2012); NY on 1 filing (Jun 28, 2019).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Apr 10, 2009 ↗Form D · Apr 13, 2009 ↗Form D · Jun 16, 2009 ↗Form D · Jun 28, 2019 ↗
Sources
Note · Apr 13, 2009 – Apr 23, 2014

Reported revenue range changed between filings — Nora Therapeutics, Inc.

"No Revenues" (Apr 13, 2009); then "Decline to Disclose" (Apr 23, 2014).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Apr 13, 2009 ↗Form D · Apr 23, 2014 ↗Nora Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jun 16, 2009 – Mar 18, 2011

Reported revenue range changed between filings — LUX BIOSCIENCES INC

"No Revenues" (Jun 16, 2009); then "Decline to Disclose" (Mar 18, 2011).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Jun 16, 2009 ↗Form D · Mar 18, 2011 ↗LUX BIOSCIENCES INC — PartnerFacts page ↗
Sources
Note · Apr 13, 2009 – Jun 2, 2010

Minimum investment changed between filings — Nora Therapeutics, Inc.

The Apr 13, 2009 filing lists a minimum of $16,291; the Jun 2, 2010 Form D/A lists $919.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Apr 13, 2009 ↗Form D/A (later) · Jun 2, 2010 ↗Nora Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jun 16, 2009 – Oct 30, 2009

Minimum investment changed between filings — LUX BIOSCIENCES INC

The Jun 16, 2009 filing lists a minimum of $21,167; the Oct 30, 2009 Form D lists $87,302.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Jun 16, 2009 ↗Form D (later) · Oct 30, 2009 ↗LUX BIOSCIENCES INC — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 21 offerings reports sales commissions totalling $1,012,000; 1 reports finder's fees totalling $4,739; 0 report proceeds to related persons.

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jun 28, 2019 D
Ajax Therapeutics, Inc.
File 021-343084
$0$0$0None listed on this filingEDGAR ↗
Oct 13, 2015 D
Nora Therapeutics, Inc.
File 021-249197
$0$0$0None listed on this filingEDGAR ↗
May 14, 2015 D
Nora Therapeutics, Inc.
File 021-239899
$0$0$0None listed on this filingEDGAR ↗
Mar 25, 2015 D
NGM BIOPHARMACEUTICALS INC
File 021-236650
$0$0$0None listed on this filingEDGAR ↗
Feb 24, 2015 D
NGM BIOPHARMACEUTICALS INC
File 021-234589
$0$0$0None listed on this filingEDGAR ↗
Apr 23, 2014 D
Nora Therapeutics, Inc.
File 021-216080
$0$0$0None listed on this filingEDGAR ↗
May 3, 2013 D
NGM BIOPHARMACEUTICALS INC
File 021-195932
$0$0$0None listed on this filingEDGAR ↗
Jan 3, 2013 D
ALVINE PHARMACEUTICALS INC
File 021-189318
$0$0$0None listed on this filingEDGAR ↗
Mar 6, 2012 D
LUX BIOSCIENCES INC
File 021-174381
$0$0$0None listed on this filingEDGAR ↗
Feb 23, 2012 D
SATORI PHARMACEUTICALS INC
File 021-173852
$0$0$0None listed on this filingEDGAR ↗
Dec 12, 2011 D
LUX BIOSCIENCES INC
File 021-169899
$0$0$0None listed on this filingEDGAR ↗
Nov 7, 2011 D/A
NGM BIOPHARMACEUTICALS INC
File 021-114428
$0$0$0None listed on this filingEDGAR ↗
Sep 15, 2011 D
KYTHERA BIOPHARMACEUTICALS INC
File 021-165882
$1,012,000$4,739$0Leerink Swann LLC BrokerCheck CRD 39011 ↗EDGAR ↗
Jul 14, 2011 D
LUX BIOSCIENCES INC
File 021-162866
$0$0$0None listed on this filingEDGAR ↗
Mar 18, 2011 D
LUX BIOSCIENCES INC
File 021-156981
$0$0$0None listed on this filingEDGAR ↗
Dec 20, 2010 D
LUX BIOSCIENCES INC
File 021-152213
$0$0$0None listed on this filingEDGAR ↗
Sep 23, 2010 D
Nora Therapeutics, Inc.
File 021-148095
$0$0$0None listed on this filingEDGAR ↗
Jun 2, 2010 D/A
Nora Therapeutics, Inc.
File 021-130159
$0$0$0None listed on this filingEDGAR ↗
Oct 30, 2009 D
LUX BIOSCIENCES INC
File 021-90990
$0$0$0None listed on this filingEDGAR ↗
Sep 4, 2009 D
Trubion Pharmaceuticals, Inc
File 021-67751
$0$0$0None listed on this filingEDGAR ↗
Aug 21, 2009 D
Gloucester Pharmaceuticals Inc
File 021-70770
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 9

Every issuer that named David Schnell on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

AT
Other

Ajax Therapeutics, Inc.

New York, NY · Jun 28, 2019
  • Jun 28, 2019 · D · $8,000,000 sold of $8,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $95M from 21 investors (100% of the $8M target) as of the latest filing. David is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NT
Biotechnology

Nora Therapeutics, Inc.

Palo Alto, CA · Apr 13, 2009 → Oct 13, 2015 · 6 filings
  • Oct 13, 2015 · D · $1,000,000 sold of $3,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 14, 2015 · D · $0 sold of $536,709 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 23, 2014 · D · $18,000,000 sold of $18,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 23, 2010 · D · $14,880,000 sold of $32,554,999 · 5 investors · min. $12,950 · role: Director EDGAR ↗
  • Jun 2, 2010 · D/A · $2,932,000 sold of $25,137,000 · 4 investors · min. $919 · role: Director EDGAR ↗
  • Apr 13, 2009 · D · $1,000,000 sold of $24,000,000 · 4 investors · min. $16,291 · role: Director EDGAR ↗

Raised $18M from 6 investors (100% of the $3M target) as of the latest filing. David is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NB
Biotechnology

NGM BIOPHARMACEUTICALS INC

South San Francisco, CA · Nov 13, 2009 → Mar 25, 2015 · 10 filings
  • Mar 25, 2015 · D · $105,999,996 sold of $105,999,996 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 24, 2015 · D · $20,710,000 sold of $60,000,000 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 3, 2013 · D · $13,485,015 sold of $50,000,001 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 7, 2011 · D/A · $55,389,000 sold of $55,664,000 · 28 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 3, 2011 · D/A · $38,459,340 sold of $55,664,000 · 28 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 3, 2010 · D/A · $21,529,670 sold of $55,664,000 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 5, 2010 · D · $17,029,670 sold of $51,139,000 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 22, 2009 · D/A · $26,550,000 sold of $26,550,000 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 10, 2009 · D/A · $24,530,431 sold of $26,550,000 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 13, 2009 · D/A · $17,616,665 sold of $26,550,000 · 18 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $106M from 28 investors (100% of the $106M target) as of the latest filing. David is listed as director on 10 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AP
Other Health Care

ALVINE PHARMACEUTICALS INC

San Carlos, CA · Jan 3, 2013
  • Jan 3, 2013 · D · $6,006,000 sold of $6,506,500 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $26.5M from 18 investors (100% of the $6.51M target) as of the latest filing. David is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

LB
Biotechnology

LUX BIOSCIENCES INC

Jersey City, NJ · Jun 16, 2009 → Mar 6, 2012 · 7 filings
  • Mar 6, 2012 · D · $16,000,000 sold of $17,110,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 12, 2011 · D · $4,000,000 sold of $4,350,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 14, 2011 · D · $6,000,000 sold of $6,000,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 18, 2011 · D · $3,000,000 sold of $4,500,000 · 10 investors · min. $6,916 · role: Director EDGAR ↗
  • Dec 20, 2010 · D · $5,000,000 sold of $5,000,000 · 10 investors · min. $11,526 · role: Director EDGAR ↗
  • Oct 30, 2009 · D · $37,940,274 sold of $49,940,274 · 10 investors · min. $87,302 · role: Director EDGAR ↗
  • Jun 16, 2009 · D · $9,200,000 sold of $9,200,000 · 10 investors · min. $21,167 · role: Director EDGAR ↗

Raised $37.9M from 10 investors (100% of the $17.1M target) as of the latest filing. David is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

SP
Pharmaceuticals

SATORI PHARMACEUTICALS INC

Cambridge, MA · Feb 23, 2012
  • Feb 23, 2012 · D · $15,000,000 sold of $19,200,000 · 0 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $15M from 3 investors (78% of the $19.2M target) as of the latest filing. David is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

KB
Pharmaceuticals

KYTHERA BIOPHARMACEUTICALS INC

Calabasas, CA · Sep 15, 2011
  • Sep 15, 2011 · D · $37,424,989 sold of $52,424,997 · 20 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $37.4M from 20 investors (71% of the $52.4M target) as of the latest filing. David is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

TP
Biotechnology

Trubion Pharmaceuticals, Inc

Seattle, WA · Sep 4, 2009
  • Sep 4, 2009 · D · $10,000,000 sold of $10,000,000 · 1 investors · min. $10,000,000 · role: Director EDGAR ↗

Raised $10M from 1 investor (100% of the $10M target) as of the latest filing. David is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

GP
Biotechnology

Gloucester Pharmaceuticals Inc

Cambridge, MA · Apr 10, 2009 → Aug 21, 2009 · 6 filings
  • Aug 21, 2009 · D · $20,324,914 sold of $28,881,642 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 12, 2009 · D · $500,000 sold of $500,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 17, 2009 · D · $500,000 sold of $500,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 10, 2009 · D · $1,500,000 sold of $1,500,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 6, 2009 · D · $1,700,000 sold of $1,700,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 10, 2009 · D · $1,500,000 sold of $1,500,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $20.3M from 9 investors (70% of the $28.9M target) as of the latest filing. David is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around David 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

CA
Management entity

Clarke Atwell

Executive Officer · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as David Schnell. Their page shows their other deals.

DH
No photo found yet (own website and image search run after this page is viewed)
Person

Donald J. Hayden

Executive Officer, Director · 12 shared filings (2 issuers) · also on 3 other issuers

Donald J. Hayden is on 5 issuers in total — a repeat sponsor. Their page lists every one.

MV
No photo found yet (own website and image search run after this page is viewed)
Person

Martin Vogelbaum

Director, Executive Officer · 11 shared filings (3 issuers) · also on 6 other issuers

Martin Vogelbaum is on 9 issuers in total — a repeat sponsor. Their page lists every one.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Svennilson

Director · 10 shared filings (1 issuer) · also on 20 other issuers

Peter Svennilson is on 21 issuers in total — a repeat sponsor. Their page lists every one.

DG
No photo found yet (own website and image search run after this page is viewed)
Person

David Goeddel

Executive Officer, Director · 10 shared filings (1 issuer) · also on 19 other issuers

David Goeddel is on 20 issuers in total — a repeat sponsor. Their page lists every one.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

Jin-Long Chen

Executive Officer, Director · 10 shared filings (1 issuer)

Listed on the same filings as David Schnell. Their page shows their other deals.

TD
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Dyrberg

Director · 8 shared filings (2 issuers) · also on 4 other issuers

Thomas Dyrberg is on 6 issuers in total — a repeat sponsor. Their page lists every one.

AL
No photo found yet (own website and image search run after this page is viewed)
Person

ARTHUR LEVINSON

Director · 8 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as David Schnell. Their page shows their other deals.

AC
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Colowick

Executive Officer, Director · 7 shared filings (2 issuers) · also on 8 other issuers

Alan Colowick is on 10 issuers in total — a repeat sponsor. Their page lists every one.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Axel Bolte

Director · 7 shared filings (1 issuer) · also on 5 other issuers

Axel Bolte is on 6 issuers in total — a repeat sponsor. Their page lists every one.

EA
No photo found yet (own website and image search run after this page is viewed)
Person

Eddy Anglade

Executive Officer · 7 shared filings (1 issuer)

Listed on the same filings as David Schnell. Their page shows their other deals.

LG
No photo found yet (own website and image search run after this page is viewed)
Person

Lutz Giebel

Director · 7 shared filings (1 issuer) · also on 7 other issuers

Lutz Giebel is on 8 issuers in total — a repeat sponsor. Their page lists every one.

DG
No photo found yet (own website and image search run after this page is viewed)
Person

David Guyer

Director · 7 shared filings (1 issuer) · also on 8 other issuers

David Guyer is on 9 issuers in total — a repeat sponsor. Their page lists every one.

PC
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Chaney

Director · 7 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as David Schnell. Their page shows their other deals.

ML
No photo found yet (own website and image search run after this page is viewed)
Person

Marc Leschly

Director · 7 shared filings (1 issuer)

Listed on the same filings as David Schnell. Their page shows their other deals.

MT
No photo found yet (own website and image search run after this page is viewed)
Person

McHenry T. Tichenor, Jr.

Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as David Schnell. Their page shows their other deals.

HK
No photo found yet (own website and image search run after this page is viewed)
Person

Helen Kim

Executive Officer · 7 shared filings (1 issuer) · also on 12 other issuers

Helen Kim is on 13 issuers in total — a repeat sponsor. Their page lists every one.

SH
No photo found yet (own website and image search run after this page is viewed)
Person

Seth Harrison

Director · 6 shared filings (1 issuer) · also on 21 other issuers

Seth Harrison is on 22 issuers in total — a repeat sponsor. Their page lists every one.

JN
No photo found yet (own website and image search run after this page is viewed)
Person

Jean C. Nichols

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as David Schnell. Their page shows their other deals.

NV
No photo found yet (own website and image search run after this page is viewed)
Person

Nicholas Vrolijk

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as David Schnell. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Jay Moorin

Director · 6 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as David Schnell. Their page shows their other deals.

CY
No photo found yet (own website and image search run after this page is viewed)
Person

Chen Yu

Director · 6 shared filings (1 issuer) · also on 10 other issuers

Chen Yu is on 11 issuers in total — a repeat sponsor. Their page lists every one.

LB
No photo found yet (own website and image search run after this page is viewed)
Person

Luis Bayol

Executive Officer · 5 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as David Schnell. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Dean Mitchell

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as David Schnell. Their page shows their other deals.

WR
No photo found yet (own website and image search run after this page is viewed)
Person

William J. Rieflin

Executive Officer, Director · 5 shared filings (1 issuer) · also on 6 other issuers

William J. Rieflin is on 7 issuers in total — a repeat sponsor. Their page lists every one.

BF
No photo found yet (own website and image search run after this page is viewed)
Person

Bryant E. Fong

Director · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as David Schnell. Their page shows their other deals.

DF
No photo found yet (own website and image search run after this page is viewed)
Person

Dennis Fenton

Director · 4 shared filings (2 issuers) · also on 4 other issuers

Dennis Fenton is on 6 issuers in total — a repeat sponsor. Their page lists every one.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey K. Tong

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as David Schnell. Their page shows their other deals.

ML
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Leschly

Director · 3 shared filings (1 issuer) · also on 10 other issuers

Mark Leschly is on 11 issuers in total — a repeat sponsor. Their page lists every one.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

Darryl L. Carter

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as David Schnell. Their page shows their other deals.

CM
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher B. McClain

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as David Schnell. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph L. Turner

Director · 3 shared filings (2 issuers) · also on 4 other issuers

Joseph L. Turner is on 6 issuers in total — a repeat sponsor. Their page lists every one.

UG
No photo found yet (own website and image search run after this page is viewed)
Person

Ulrich M. Grau

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as David Schnell. Their page shows their other deals.

GE
No photo found yet (own website and image search run after this page is viewed)
Person

George Eldridge

Executive Officer · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as David Schnell. Their page shows their other deals.

AD
No photo found yet (own website and image search run after this page is viewed)
Person

Anupam Dalal

Director · 2 shared filings (1 issuer) · also on 8 other issuers

Anupam Dalal is on 9 issuers in total — a repeat sponsor. Their page lists every one.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Brett Skolnik

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as David Schnell. Their page shows their other deals.

PT
No photo found yet (own website and image search run after this page is viewed)
Person

Peter A. Thompson

Executive Officer, Director · 1 shared filing (1 issuer) · also on 28 other issuers

Peter A. Thompson is on 29 issuers in total — a repeat sponsor. Their page lists every one.

KL
No photo found yet (own website and image search run after this page is viewed)
Person

Keith Leonard

Executive Officer, Director · 1 shared filing (1 issuer) · also on 4 other issuers

Keith Leonard is on 5 issuers in total — a repeat sponsor. Their page lists every one.

ND
No photo found yet (own website and image search run after this page is viewed)
Person

Nathaniel David

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as David Schnell. Their page shows their other deals.

NK
No photo found yet (own website and image search run after this page is viewed)
Person

Nina Kjellson

Director · 1 shared filing (1 issuer) · also on 13 other issuers

Nina Kjellson is on 14 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 9 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to David Schnell by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 9 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers David Schnell is listed on: none on file. No website or social profile named in KYTHERA BIOPHARMACEUTICALS INC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #349,478 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Calabasas, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗New Jersey state courts — find the court ↗Massachusetts MassCourts ↗California — find the county court ↗Los Angeles Superior Court case search ↗New York WebCivil Supreme ↗Washington Courts case search (dw.courts.wa.gov) ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

New Jersey Secretary of State business search ↗Massachusetts Secretary of State business search ↗California Secretary of State business search ↗New York Secretary of State business search ↗Washington Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when David Schnell appears on a new Form D, or when a court case or SEC action is matched to them. See plans →